Skip to main content
Top
Published in: Arthritis Research & Therapy 4/2007

Open Access 01-08-2007 | Research article

Mesangial cells of lupus-prone mice are sensitive to chemokine production

Authors: Shuk-Man Ka, Chao-Wen Cheng, Hao-Ai Shui, Wen-Mein Wu, Deh-Ming Chang, Yu-Chu Lin, Ann Chen

Published in: Arthritis Research & Therapy | Issue 4/2007

Login to get access

Abstract

Infectious antigens may be triggers for the exacerbation of systemic lupus erythematosus. The underlying mechanism causing acceleration and exacerbation of lupus nephritis (LN) is largely unknown. Bacterial lipopolysaccharide (LPS) is capable of inducing an accelerated model of LN in NZB/W mice, featuring diffuse proliferation of glomerular resident cells. We hypothesized that mesangial cells (MCs) from LN subjects are more responsive to LPS than normal subjects. Cultured primary NZB/W and DBA/W (nonautoimmune disease-prone strain with MHC class II molecules identical to those of NZB/W) MCs were used. Monocyte chemoattractant protein-1 (MCP-1) and osteopontin (OPN) expressions either in the baseline (normal culture) condition or in the presence of LPS were evaluated by real-time PCR, ELISA, or western blot analysis. NF-κB was detected by ELISA, electrophoresis mobility-shift assay, and immunofluorescence. First, either in the baseline condition or in the presence of LPS, NZB/W MCs produced significantly higher levels of MCP-1 and OPN than the DBA/W MC controls. Second, NZB/W MCs expressed significantly higher levels of Toll-like receptor 4, myeloid differentiation factor 88, and NF-κB than the DBA/W MC controls, both receiving exactly the same LPS treatment. In conclusion, NZB/W MCs are significantly more sensitive than their normal control DBA/W MCs in producing both MCP-1 and OPN. With LPS treatment, the significantly elevated levels of both chemokines produced by NZB/W MCs are more likely due to a significantly greater activation of the Toll-like receptor 4-myeloid differentiation factor 88-associated NF-κB pathway. The observed abnormal molecular events provide an intrarenal pathogenic pathway involved in an accelerated type of LN, which is potentially infection triggered.
Appendix
Available only for authorised users
Literature
1.
go back to reference Waldman M, Madaio MP: Pathogenic autoantibodies in lupus nephritis. Lupus. 2005, 14: 19-24. 10.1191/0961203305lu2054oa.CrossRefPubMed Waldman M, Madaio MP: Pathogenic autoantibodies in lupus nephritis. Lupus. 2005, 14: 19-24. 10.1191/0961203305lu2054oa.CrossRefPubMed
2.
go back to reference Zandman-Goddard G, Shoenfeld Y: Infections and SLE. Autoimmunity. 2005, 38: 473-485. 10.1080/08916930500285352.CrossRefPubMed Zandman-Goddard G, Shoenfeld Y: Infections and SLE. Autoimmunity. 2005, 38: 473-485. 10.1080/08916930500285352.CrossRefPubMed
4.
go back to reference Cavallo T, Granholm NA: Bacterial lipopolysaccharide transforms mesangial into proliferative lupus nephritis without interfering with processing of pathogenic immune complexes in NZB/W mice. Am J Pathol. 1990, 137: 971-978.PubMedCentralPubMed Cavallo T, Granholm NA: Bacterial lipopolysaccharide transforms mesangial into proliferative lupus nephritis without interfering with processing of pathogenic immune complexes in NZB/W mice. Am J Pathol. 1990, 137: 971-978.PubMedCentralPubMed
5.
go back to reference Wang Y, Rangan GK, Goodwin B, Tay YC, Harris DC: Lipopolysaccharide-induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-kappaB dependent. Kidney Int. 2000, 57: 2011-2022. 10.1046/j.1523-1755.2000.00051.x.CrossRefPubMed Wang Y, Rangan GK, Goodwin B, Tay YC, Harris DC: Lipopolysaccharide-induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-kappaB dependent. Kidney Int. 2000, 57: 2011-2022. 10.1046/j.1523-1755.2000.00051.x.CrossRefPubMed
6.
go back to reference Pawluczyk IZ, Harris KP: Macrophages promote prosclerotic responses in cultured rat mesangial cells: a mechanism for the initiation of glomerulosclerosis. J Am Soc Nephrol. 1997, 8: 1525-1536.PubMed Pawluczyk IZ, Harris KP: Macrophages promote prosclerotic responses in cultured rat mesangial cells: a mechanism for the initiation of glomerulosclerosis. J Am Soc Nephrol. 1997, 8: 1525-1536.PubMed
7.
go back to reference Schlondorff D: The role of chemokines in the initiation and progression of renal disease. Kidney Int Suppl. 1995, 49: S44-S47.PubMed Schlondorff D: The role of chemokines in the initiation and progression of renal disease. Kidney Int Suppl. 1995, 49: S44-S47.PubMed
8.
go back to reference Carr MW, Roth SJ, Luther E, Rose SS, Springer TA: Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A. 1994, 91: 3652-3656. 10.1073/pnas.91.9.3652.PubMedCentralCrossRefPubMed Carr MW, Roth SJ, Luther E, Rose SS, Springer TA: Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A. 1994, 91: 3652-3656. 10.1073/pnas.91.9.3652.PubMedCentralCrossRefPubMed
9.
go back to reference Mezzano SA, Barria M, Droguett MA, Burgos ME, Ardiles LG, Flores C, Egido J: Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. Kidney Int. 2001, 60: 1366-1377. 10.1046/j.1523-1755.2001.00941.x.CrossRefPubMed Mezzano SA, Barria M, Droguett MA, Burgos ME, Ardiles LG, Flores C, Egido J: Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. Kidney Int. 2001, 60: 1366-1377. 10.1046/j.1523-1755.2001.00941.x.CrossRefPubMed
10.
go back to reference Rovin BH, Yoshiumura T, Tan L: Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol. 1992, 148: 2148-2153.PubMed Rovin BH, Yoshiumura T, Tan L: Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol. 1992, 148: 2148-2153.PubMed
11.
go back to reference Prodjosudjadi W, Gerritsma JS, Klar-Mohamad N, Gerritsen AF, Bruijn JA, Daha MR, van Es LA: Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int. 1995, 48: 1477-1486. 10.1038/ki.1995.437.CrossRefPubMed Prodjosudjadi W, Gerritsma JS, Klar-Mohamad N, Gerritsen AF, Bruijn JA, Daha MR, van Es LA: Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int. 1995, 48: 1477-1486. 10.1038/ki.1995.437.CrossRefPubMed
12.
go back to reference Lan HY, Yu XQ, Yang N, Nikolic-Paterson DJ, Mu W, Pichler R, Johnson RJ, Atkins RC: De novo glomerular osteopontin expression in rat crescentic glomerulonephritis. Kidney Int. 1998, 53: 136-145. 10.1046/j.1523-1755.1998.00748.x.CrossRefPubMed Lan HY, Yu XQ, Yang N, Nikolic-Paterson DJ, Mu W, Pichler R, Johnson RJ, Atkins RC: De novo glomerular osteopontin expression in rat crescentic glomerulonephritis. Kidney Int. 1998, 53: 136-145. 10.1046/j.1523-1755.1998.00748.x.CrossRefPubMed
13.
go back to reference Ka SM, Rifai A, Chen JH, Cheng CW, Shui HA, Lee HS, Lin YF, Hsu LF, Chen A: Glomerular crescent-related biomarkers in a murine model of chronic graft versus host disease. Nephrol Dial Transplant. 2006, 21: 288-298. 10.1093/ndt/gfi229.CrossRefPubMed Ka SM, Rifai A, Chen JH, Cheng CW, Shui HA, Lee HS, Lin YF, Hsu LF, Chen A: Glomerular crescent-related biomarkers in a murine model of chronic graft versus host disease. Nephrol Dial Transplant. 2006, 21: 288-298. 10.1093/ndt/gfi229.CrossRefPubMed
14.
go back to reference Hudkins KL, Giachelli CM, Eitner F, Couser WG, Johnson RJ, Alpers CE: Osteopontin expression in human crescentic glomerulonephritis. Kidney Int. 2000, 57: 105-116. 10.1046/j.1523-1755.2000.00813.x.CrossRefPubMed Hudkins KL, Giachelli CM, Eitner F, Couser WG, Johnson RJ, Alpers CE: Osteopontin expression in human crescentic glomerulonephritis. Kidney Int. 2000, 57: 105-116. 10.1046/j.1523-1755.2000.00813.x.CrossRefPubMed
15.
go back to reference Prols F, Heidgress D, Rupprecht HD, Marx M: Regulation of osteopontin expression in rat mesangial cells. FEBS Lett. 1998, 422: 15-18. 10.1016/S0014-5793(97)01587-1.CrossRefPubMed Prols F, Heidgress D, Rupprecht HD, Marx M: Regulation of osteopontin expression in rat mesangial cells. FEBS Lett. 1998, 422: 15-18. 10.1016/S0014-5793(97)01587-1.CrossRefPubMed
16.
go back to reference Nagasaki T, Ishimura E, Shioi A, Jono S, Inaba M, Nishizawa Y, Morii H, Otani S: Osteopontin gene expression and protein synthesis in cultured rat mesangial cells. Biochem Biophys Res Commun. 1997, 233: 81-85. 10.1006/bbrc.1997.6399.CrossRefPubMed Nagasaki T, Ishimura E, Shioi A, Jono S, Inaba M, Nishizawa Y, Morii H, Otani S: Osteopontin gene expression and protein synthesis in cultured rat mesangial cells. Biochem Biophys Res Commun. 1997, 233: 81-85. 10.1006/bbrc.1997.6399.CrossRefPubMed
17.
go back to reference Wuthrich RP, Fan X, Ritthaler T, Sibalic V, Yu DJ, Loffing J, Kaissling B: Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis. Autoimmunity. 1998, 28: 139-150.CrossRefPubMed Wuthrich RP, Fan X, Ritthaler T, Sibalic V, Yu DJ, Loffing J, Kaissling B: Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis. Autoimmunity. 1998, 28: 139-150.CrossRefPubMed
18.
go back to reference Denny MF, Chandaroy P, Killen PD, Caricchio R, Lewis EE, Richardson BC, Lee KD, Gavalchin J, Kaplan MJ: Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus. J Immunol. 2006, 176: 2095-2104.CrossRefPubMed Denny MF, Chandaroy P, Killen PD, Caricchio R, Lewis EE, Richardson BC, Lee KD, Gavalchin J, Kaplan MJ: Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus. J Immunol. 2006, 176: 2095-2104.CrossRefPubMed
19.
go back to reference Tesch GH, Maifert S, Schwarting A, Rollins BJ, Kelley VR: Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med. 1999, 190: 1813-1824. 10.1084/jem.190.12.1813.PubMedCentralCrossRefPubMed Tesch GH, Maifert S, Schwarting A, Rollins BJ, Kelley VR: Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med. 1999, 190: 1813-1824. 10.1084/jem.190.12.1813.PubMedCentralCrossRefPubMed
20.
go back to reference Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, Nagai Y, Takeuchi O, Akira S, Matsuguchi T: Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol. 2002, 169: 2026-2033.CrossRefPubMed Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, Nagai Y, Takeuchi O, Akira S, Matsuguchi T: Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol. 2002, 169: 2026-2033.CrossRefPubMed
21.
go back to reference Patole PS, Grone HJ, Segerer S, Ciubar R, Belemezova E, Henger A, Kretzler M, Schlondorff D, Anders HJ: Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J Am Soc Nephrol. 2005, 16: 1326-1338. 10.1681/ASN.2004100820.CrossRefPubMed Patole PS, Grone HJ, Segerer S, Ciubar R, Belemezova E, Henger A, Kretzler M, Schlondorff D, Anders HJ: Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J Am Soc Nephrol. 2005, 16: 1326-1338. 10.1681/ASN.2004100820.CrossRefPubMed
22.
go back to reference Fu Y, Xie C, Chen J, Zhu J, Zhou H, Thomas J, Zhou XJ, Mohan C: Innate stimuli accentuate end-organ damage by nephrotoxic antibodies via Fc receptor and TLR stimulation and IL-1/TNF-alpha production. J Immunol. 2006, 176: 632-639.CrossRefPubMed Fu Y, Xie C, Chen J, Zhu J, Zhou H, Thomas J, Zhou XJ, Mohan C: Innate stimuli accentuate end-organ damage by nephrotoxic antibodies via Fc receptor and TLR stimulation and IL-1/TNF-alpha production. J Immunol. 2006, 176: 632-639.CrossRefPubMed
23.
go back to reference Zhang G, Ghosh S: Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest. 2001, 107: 13-19.PubMedCentralCrossRefPubMed Zhang G, Ghosh S: Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest. 2001, 107: 13-19.PubMedCentralCrossRefPubMed
24.
go back to reference Suen JL, Wu CH, Chen YY, Wu WM, Chiang BL: Characterization of self-T-cell response and antigenic determinants of U1A protein with bone marrow-derived dendritic cells in NZB × NZW F1 mice. Immunology. 2001, 103: 301-309. 10.1046/j.1365-2567.2001.01255.x.PubMedCentralCrossRefPubMed Suen JL, Wu CH, Chen YY, Wu WM, Chiang BL: Characterization of self-T-cell response and antigenic determinants of U1A protein with bone marrow-derived dendritic cells in NZB × NZW F1 mice. Immunology. 2001, 103: 301-309. 10.1046/j.1365-2567.2001.01255.x.PubMedCentralCrossRefPubMed
25.
go back to reference Groggel GC, Marinides GN, Hovingh P, Hammond E, Linker A: Inhibition of rat mesangial cell growth by heparan sulfate. Am J Physiol. 1990, 258: F259-F265.PubMed Groggel GC, Marinides GN, Hovingh P, Hammond E, Linker A: Inhibition of rat mesangial cell growth by heparan sulfate. Am J Physiol. 1990, 258: F259-F265.PubMed
26.
go back to reference Shui HA, Ka SM, Wu WM, Lin YF, Hou YC, Su LC, Chen A: LPS-evoked IL-18 expression in mesangial cells plays a role in accelerating lupus nephritis. Rheumatology. 2007, Jun 14 Shui HA, Ka SM, Wu WM, Lin YF, Hou YC, Su LC, Chen A: LPS-evoked IL-18 expression in mesangial cells plays a role in accelerating lupus nephritis. Rheumatology. 2007, Jun 14
27.
go back to reference Su SL, Tsai CD, Lee CH, Salter DM, Lee HS: Expression and regulation of Toll-like receptor 2 by IL-1beta and fibronectin fragments in human articular chondrocytes. Osteoarthritis Cartilage. 2005, 13: 879-886. 10.1016/j.joca.2005.04.017.CrossRefPubMed Su SL, Tsai CD, Lee CH, Salter DM, Lee HS: Expression and regulation of Toll-like receptor 2 by IL-1beta and fibronectin fragments in human articular chondrocytes. Osteoarthritis Cartilage. 2005, 13: 879-886. 10.1016/j.joca.2005.04.017.CrossRefPubMed
28.
go back to reference Beutler B, Hoebe K, Du X, Ulevitch RJ: How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol. 2003, 74: 479-485. 10.1189/jlb.0203082.CrossRefPubMed Beutler B, Hoebe K, Du X, Ulevitch RJ: How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol. 2003, 74: 479-485. 10.1189/jlb.0203082.CrossRefPubMed
29.
go back to reference Gioannini TL, Teghanemt A, Zhang D, Coussens NP, Dockstader W, Ramaswamy S, Weiss JP: Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc Natl Acad Sci U S A. 2004, 101: 4186-4191. 10.1073/pnas.0306906101.PubMedCentralCrossRefPubMed Gioannini TL, Teghanemt A, Zhang D, Coussens NP, Dockstader W, Ramaswamy S, Weiss JP: Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc Natl Acad Sci U S A. 2004, 101: 4186-4191. 10.1073/pnas.0306906101.PubMedCentralCrossRefPubMed
30.
go back to reference Chan RW, Lai FM, Li EK, Tam LS, Wong TY, Szeto CY, Li PK, Szeto CC: Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis. Arthritis Rheum. 2004, 50: 2882-2890. 10.1002/art.20471.CrossRefPubMed Chan RW, Lai FM, Li EK, Tam LS, Wong TY, Szeto CY, Li PK, Szeto CC: Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis. Arthritis Rheum. 2004, 50: 2882-2890. 10.1002/art.20471.CrossRefPubMed
31.
go back to reference Chan RW, Lai FM, Li EK, Tam LS, Chow KM, Li PK, Szeto CC: The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis. Nephrol Dial Transplant. 2006, 21: 1534-1540. 10.1093/ndt/gfk102.CrossRefPubMed Chan RW, Lai FM, Li EK, Tam LS, Chow KM, Li PK, Szeto CC: The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis. Nephrol Dial Transplant. 2006, 21: 1534-1540. 10.1093/ndt/gfk102.CrossRefPubMed
32.
go back to reference Haberstroh U, Pocock J, Gomez-Guerrero C, Helmchen U, Hamann A, Gutierrez-Ramos JC, Stahl RA, Thaiss F: Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells. Kidney Int. 2002, 62: 1264-1276. 10.1111/j.1523-1755.2002.kid572.x.CrossRefPubMed Haberstroh U, Pocock J, Gomez-Guerrero C, Helmchen U, Hamann A, Gutierrez-Ramos JC, Stahl RA, Thaiss F: Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells. Kidney Int. 2002, 62: 1264-1276. 10.1111/j.1523-1755.2002.kid572.x.CrossRefPubMed
33.
go back to reference Ding L, Zhao M, Zou W, Liu Y, Wang H: Mycophenolate mofetil combined with prednisone for diffuse proliferative lupus nephritis: a histopathological study. Lupus. 2004, 13: 113-118. 10.1191/0961203304lu513oa.CrossRefPubMed Ding L, Zhao M, Zou W, Liu Y, Wang H: Mycophenolate mofetil combined with prednisone for diffuse proliferative lupus nephritis: a histopathological study. Lupus. 2004, 13: 113-118. 10.1191/0961203304lu513oa.CrossRefPubMed
34.
go back to reference Sodhi CP, Batlle D, Sahai A: Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: role of PKC and p38 MAPK. Kidney Int. 2000, 58: 691-700. 10.1046/j.1523-1755.2000.00215.x.CrossRefPubMed Sodhi CP, Batlle D, Sahai A: Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: role of PKC and p38 MAPK. Kidney Int. 2000, 58: 691-700. 10.1046/j.1523-1755.2000.00215.x.CrossRefPubMed
35.
go back to reference Fournie GJ, Minh MG, Mignon-Conte MA, Hass S, Lambert PH, Conte JJ: Acceleration of glomerulonephritis in NZB × NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB × NZW mouse disease. J Clin Lab Immunol. 1980, 4: 103-106.PubMed Fournie GJ, Minh MG, Mignon-Conte MA, Hass S, Lambert PH, Conte JJ: Acceleration of glomerulonephritis in NZB × NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB × NZW mouse disease. J Clin Lab Immunol. 1980, 4: 103-106.PubMed
36.
go back to reference Harada K, Ohira S, Isse K, Ozaki S, Zen Y, Sato Y, Nakanuma Y: Lipopolysaccharide activates nuclear factor-kappaB through toll-like receptors and related molecules in cultured biliary epithelial cells. Lab Invest. 2003, 83: 1657-1667. 10.1097/01.LAB.0000097190.56734.FE.CrossRefPubMed Harada K, Ohira S, Isse K, Ozaki S, Zen Y, Sato Y, Nakanuma Y: Lipopolysaccharide activates nuclear factor-kappaB through toll-like receptors and related molecules in cultured biliary epithelial cells. Lab Invest. 2003, 83: 1657-1667. 10.1097/01.LAB.0000097190.56734.FE.CrossRefPubMed
37.
go back to reference Ogawa T, Asai Y, Hashimoto M, Takeuchi O, Kurita T, Yoshikai Y, Miyake K, Akira S: Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway. Int Immunol. 2002, 14: 1325-1332. 10.1093/intimm/dxf097.CrossRefPubMed Ogawa T, Asai Y, Hashimoto M, Takeuchi O, Kurita T, Yoshikai Y, Miyake K, Akira S: Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway. Int Immunol. 2002, 14: 1325-1332. 10.1093/intimm/dxf097.CrossRefPubMed
38.
go back to reference Zughaier SM, Zimmer SM, Datta A, Carlson RW, Stephens DS: Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect Immun. 2005, 73: 2940-2950. 10.1128/IAI.73.5.2940-2950.2005.PubMedCentralCrossRefPubMed Zughaier SM, Zimmer SM, Datta A, Carlson RW, Stephens DS: Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect Immun. 2005, 73: 2940-2950. 10.1128/IAI.73.5.2940-2950.2005.PubMedCentralCrossRefPubMed
39.
go back to reference Barnes PJ, Karin M: Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997, 336: 1066-1071. 10.1056/NEJM199704103361506.CrossRefPubMed Barnes PJ, Karin M: Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997, 336: 1066-1071. 10.1056/NEJM199704103361506.CrossRefPubMed
40.
go back to reference Tsukinoki T, Sugiyama H, Sunami R, Kobayashi M, Onoda T, Maeshima Y, Yamasaki Y, Makino H: Mesangial cell Fas ligand: upregulation in human lupus nephritis and NF-kappaB-mediated expression in cultured human mesangial cells. Clin Exp Nephrol. 2004, 8: 196-205. 10.1007/s10157-004-0301-3.CrossRefPubMed Tsukinoki T, Sugiyama H, Sunami R, Kobayashi M, Onoda T, Maeshima Y, Yamasaki Y, Makino H: Mesangial cell Fas ligand: upregulation in human lupus nephritis and NF-kappaB-mediated expression in cultured human mesangial cells. Clin Exp Nephrol. 2004, 8: 196-205. 10.1007/s10157-004-0301-3.CrossRefPubMed
41.
go back to reference Brown HJ, Lock HR, Sacks SH, Robson MG: TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis. J Immunol. 2006, 177: 1925-1931.CrossRefPubMed Brown HJ, Lock HR, Sacks SH, Robson MG: TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis. J Immunol. 2006, 177: 1925-1931.CrossRefPubMed
42.
go back to reference Wilmer WA, Kaumaya PT, Ember JA, Cosio FG: Receptors for the anaphylatoxin C5a (CD88) on human mesangial cells. J Immunol. 1998, 160: 5646-5652.PubMed Wilmer WA, Kaumaya PT, Ember JA, Cosio FG: Receptors for the anaphylatoxin C5a (CD88) on human mesangial cells. J Immunol. 1998, 160: 5646-5652.PubMed
43.
go back to reference Wakeland EK, Liu K, Graham RR, Behrens TW: Delineating the genetic basis of systemic lupus erythematosus. Immunity. 2001, 15: 397-408. 10.1016/S1074-7613(01)00201-1.CrossRefPubMed Wakeland EK, Liu K, Graham RR, Behrens TW: Delineating the genetic basis of systemic lupus erythematosus. Immunity. 2001, 15: 397-408. 10.1016/S1074-7613(01)00201-1.CrossRefPubMed
44.
go back to reference Kikuchi S, Santiago-Raber ML, Amano H, Amano E, Fossati-Jimack L, Moll T, Kotzin BL, Izui S: Contribution of NZB autoimmunity 2 to Y-linked autoimmune acceleration-induced monocytosis in association with murine systemic lupus. J Immunol. 2006, 176: 3240-3247.CrossRefPubMed Kikuchi S, Santiago-Raber ML, Amano H, Amano E, Fossati-Jimack L, Moll T, Kotzin BL, Izui S: Contribution of NZB autoimmunity 2 to Y-linked autoimmune acceleration-induced monocytosis in association with murine systemic lupus. J Immunol. 2006, 176: 3240-3247.CrossRefPubMed
Metadata
Title
Mesangial cells of lupus-prone mice are sensitive to chemokine production
Authors
Shuk-Man Ka
Chao-Wen Cheng
Hao-Ai Shui
Wen-Mein Wu
Deh-Ming Chang
Yu-Chu Lin
Ann Chen
Publication date
01-08-2007
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 4/2007
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2226

Other articles of this Issue 4/2007

Arthritis Research & Therapy 4/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.